HIMS Hims & Hers Health Inc

  1. Stocks
  2. Consumer Defensive
  3. NYSE: HIMS

Price (delayed)

$32.96

Market cap

$7.63B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$8.54B

?
Relative Growth: Rel. Growth: 35
Relative Strength: Rel. Strength: 46
Relative Valuation: Rel. Valuation: 16
Relative Profitability: Rel. Profitability: 34

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual ...

Highlights
Hims & Hers Health's revenue has increased by 33% YoY
HIMS's gross profit is up by 24% YoY
Hims & Hers Health's quick ratio has increased by 26% YoY but it has decreased by 3.3% QoQ
HIMS's net income has dropped by 110% since the previous quarter and by 108% year-on-year
Hims & Hers Health's EPS has shrunk by 109% QoQ and by 107% YoY
Sector: Consumer Defensive
Industry: Household & Personal Products
Website: http://www.forhims.com
Peers: NVAX NVCR NBIX

Key stats

What are the main financial stats of HIMS

HIMS stock price

How has the Hims & Hers Health stock price performed over time
Intraday
-1.73%
1 week
4.73%
1 month
38.78%
1 year
-21.49%
YTD
1.51%
QTD
58.77%

Financial performance

How have Hims & Hers Health's revenue and profit performed over time
Revenue
$2.37B
Gross profit
$1.7B
Operating income
-$30.61M
Net income
-$13.24M
Gross margin
71.7%
Net margin
-0.6%
The operating income has shrunk by 129% QoQ and by 128% YoY
The company's operating margin has shrunk by 129% QoQ and by 121% YoY
The net margin has plunged by 111% from the previous quarter and by 107% YoY
HIMS's net income has dropped by 110% since the previous quarter and by 108% year-on-year

Price vs fundamentals

How does HIMS's price correlate with its fundamentals

Growth

What is Hims & Hers Health's growth rate over time

Valuation

What is Hims & Hers Health stock price valuation
HIMS P/E details
P/E
N/A
P/B
16.84
P/S
3.18
EV/EBIT
N/A
EV/EBITDA
189.13
EV/Sales
3.6
Hims & Hers Health's EPS has shrunk by 109% QoQ and by 107% YoY
The price to book (P/B) is 99% higher than the 5-year quarterly average of 8.6 and 3.8% higher than the last 4 quarters average of 16.5
The equity has declined by 19% year-on-year and by 18% since the previous quarter
Hims & Hers Health's revenue has increased by 33% YoY
The P/S is 21% lower than the last 4 quarters average of 4.1 and 15% lower than the 5-year quarterly average of 3.8

Efficiency

How efficient is Hims & Hers Health business performance
Hims & Hers Health's return on sales has shrunk by 130% QoQ and by 124% YoY
The ROIC has dropped by 124% since the previous quarter and by 103% year-on-year
The ROE has plunged by 111% from the previous quarter and by 107% YoY
The company's return on assets has shrunk by 108% QoQ and by 102% YoY

Dividends

What is HIMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HIMS.

Financial health

How did Hims & Hers Health financials performed over time
Hims & Hers Health's total assets is 25% higher than its total liabilities
Hims & Hers Health's total assets has surged by 154% YoY and by 5% QoQ
Hims & Hers Health's quick ratio has increased by 26% YoY but it has decreased by 3.3% QoQ
The debt is 154% more than the equity
Hims & Hers Health's debt to equity has increased by 23% from the previous quarter
The equity has declined by 19% year-on-year and by 18% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.